{"id":"https://openalex.org/W2897435158","doi":"https://doi.org/10.1093/ofid/ofy210.1626","title":"1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults","display_name":"1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults","publication_year":2018,"publication_date":"2018-11-01","ids":{"openalex":"https://openalex.org/W2897435158","doi":"https://doi.org/10.1093/ofid/ofy210.1626","mag":"2897435158"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofy210.1626","doi":"https://doi.org/10.1093/ofid/ofy210.1626","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.1626","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofy210.1626","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019035418","display_name":"Joseph E. Eiden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Eiden","raw_affiliation_strings":["Celyn Consulting, LLC, Lewes, Delaware"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celyn Consulting, LLC, Lewes, Delaware","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008126863","display_name":"Gilad Gordon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gilad Gordon","raw_affiliation_strings":["ORRA Group, LLC, Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ORRA Group, LLC, Boulder, Colorado","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112918591","display_name":"Carlos A. Fierro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166038","display_name":"Johnson County Clin-Trials (United States)","ror":"https://ror.org/05nds5y03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210166038"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos Fierro","raw_affiliation_strings":["Johnson County Clin-Trials, Lenexa, Kansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson County Clin-Trials, Lenexa, Kansas","institution_ids":["https://openalex.org/I4210166038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036112915","display_name":"Robert B. Belshe","orcid":"https://orcid.org/0000-0003-0940-7213","observed_orcids":["https://orcid.org/0000-0003-0940-7213"]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Belshe","raw_affiliation_strings":["Saint Louis University, St. Louis, Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Saint Louis University, St. Louis, Missouri","institution_ids":["https://openalex.org/I47838141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012961085","display_name":"Harry B. Greenberg","orcid":"https://orcid.org/0000-0002-2128-9080","observed_orcids":["https://orcid.org/0000-0002-2128-9080"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harry Greenberg","raw_affiliation_strings":["Stanford University, Stanford, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Stanford, California","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005259317","display_name":"Dan F. Hoft","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan Hoft","raw_affiliation_strings":["Saint Louis University, St. Louis, Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Saint Louis University, St. Louis, Missouri","institution_ids":["https://openalex.org/I47838141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021483994","display_name":"Yasuko Hatta","orcid":"https://orcid.org/0009-0000-1024-3792","observed_orcids":["https://orcid.org/0009-0000-1024-3792"]},"institutions":[{"id":"https://openalex.org/I4210152934","display_name":"FluGen (United States)","ror":"https://ror.org/04p1hy645","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152934"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yasuko Hatta","raw_affiliation_strings":["FluGen, Inc., Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FluGen, Inc., Madison, WI","institution_ids":["https://openalex.org/I4210152934"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034702385","display_name":"Michael Imboden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152934","display_name":"FluGen (United States)","ror":"https://ror.org/04p1hy645","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152934"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Imboden","raw_affiliation_strings":["FluGen, Inc., Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FluGen, Inc., Madison, WI","institution_ids":["https://openalex.org/I4210152934"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mike Moser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152934","display_name":"FluGen (United States)","ror":"https://ror.org/04p1hy645","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152934"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mike Moser","raw_affiliation_strings":["FluGen, Inc., Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FluGen, Inc., Madison, WI","institution_ids":["https://openalex.org/I4210152934"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011603778","display_name":"Renee Herber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152934","display_name":"FluGen (United States)","ror":"https://ror.org/04p1hy645","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152934"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renee Herber","raw_affiliation_strings":["FluGen, Inc., Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FluGen, Inc., Madison, WI","institution_ids":["https://openalex.org/I4210152934"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074433153","display_name":"David A. Boltz","orcid":"https://orcid.org/0000-0003-4606-3974","observed_orcids":["https://orcid.org/0000-0003-4606-3974"]},"institutions":[{"id":"https://openalex.org/I1310264347","display_name":"IIT Research Institute","ror":"https://ror.org/057jp7h82","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1310264347"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Boltz","raw_affiliation_strings":["IIT Research Institute, Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IIT Research Institute, Chicago, Illinois","institution_ids":["https://openalex.org/I1310264347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064125084","display_name":"Magdalena Tary\u2010Lehmann","orcid":"https://orcid.org/0000-0002-0709-1609","observed_orcids":["https://orcid.org/0000-0002-0709-1609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Magdalena Tary-Lehmann","raw_affiliation_strings":["Cellular Technology Limited, Shaker Heights, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Technology Limited, Shaker Heights, Ohio","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076363097","display_name":"Yoshihiro Kawaoka","orcid":"https://orcid.org/0000-0001-5061-8296","observed_orcids":["https://orcid.org/0000-0001-5061-8296"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoshihiro Kawaoka","raw_affiliation_strings":["Influenza Research Institute, University of Wisconsin, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Influenza Research Institute, University of Wisconsin, Madison, Wisconsin","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064426145","display_name":"Gabriele Neumann","orcid":"https://orcid.org/0000-0001-7054-1775","observed_orcids":["https://orcid.org/0000-0001-7054-1775"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriele Neumann","raw_affiliation_strings":["Influenza Research Institute, University of Wisconsin, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Influenza Research Institute, University of Wisconsin, Madison, Wisconsin","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040397198","display_name":"Paul Radspinner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152934","display_name":"FluGen (United States)","ror":"https://ror.org/04p1hy645","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152934"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Radspinner","raw_affiliation_strings":["FluGen, Inc., Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FluGen, Inc., Madison, WI","institution_ids":["https://openalex.org/I4210152934"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110221912","display_name":"Roger Aitchison","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roger Aitchison","raw_affiliation_strings":["North Rim Consulting, Denver, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Rim Consulting, Denver, Colorado","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012993279","display_name":"Pamuk Bilsel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152934","display_name":"FluGen (United States)","ror":"https://ror.org/04p1hy645","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152934"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamuk Bilsel","raw_affiliation_strings":["FluGen, Inc., Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FluGen, Inc., Madison, WI","institution_ids":["https://openalex.org/I4210152934"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.1953,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.57138706,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"5","issue":"suppl_1","first_page":"S571","last_page":"S572"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/live-attenuated-influenza-vaccine","display_name":"live attenuated influenza vaccine","score":0.7630000114440918},{"id":"https://openalex.org/keywords/intranasal-immunization","display_name":"intranasal immunization","score":0.7749999761581421},{"id":"https://openalex.org/keywords/h3n2","display_name":"H3N2","score":0.6539999842643738},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.6809999942779541},{"id":"https://openalex.org/keywords/vaccine-immunogenicity","display_name":"vaccine immunogenicity","score":0.6769999861717224},{"id":"https://openalex.org/keywords/mucosal-antibody-response","display_name":"mucosal antibody response","score":0.7910000085830688},{"id":"https://openalex.org/keywords/b-cell-response","display_name":"B cell response","score":0.7089999914169312},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4880000054836273},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6759999990463257},{"id":"https://openalex.org/keywords/influenza-a-subtypes","display_name":"influenza A subtypes","score":0.4779999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9158357977867126},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.7724981307983398},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.6569656729698181},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5964223146438599},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5590968132019043},{"id":"https://openalex.org/C12590798","wikidata":"https://www.wikidata.org/wiki/Q3933199","display_name":"Replication (statistics)","level":2,"score":0.5020191669464111},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.501248836517334},{"id":"https://openalex.org/C2780689484","wikidata":"https://www.wikidata.org/wiki/Q383260","display_name":"Influenza vaccine","level":3,"score":0.4693489968776703},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.4291473627090454}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofy210.1626","doi":"https://doi.org/10.1093/ofid/ofy210.1626","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.1626","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5238971","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6254821","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6254821","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6254821","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofy210.1626","doi":"https://doi.org/10.1093/ofid/ofy210.1626","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.1626","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.6399999856948853,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3216727140","https://openalex.org/W2982103944","https://openalex.org/W4308637411","https://openalex.org/W3120296651","https://openalex.org/W4400677638","https://openalex.org/W2527254702","https://openalex.org/W2731678993","https://openalex.org/W4389030222","https://openalex.org/W3185304769","https://openalex.org/W4400519671"],"abstract_inverted_index":{"Influenza":[0],"vaccines":[1],"are":[2],"needed":[3],"with":[4,100,123],"greater":[5],"effectiveness":[6],"and":[7,33,36,72,110,148,151,164,225,237,254,260,292,307,313,317,341,363,372,388,396,404,412,433,453,456,470],"breadth":[8],"of":[9,29,52,129,227],"coverage.":[10],"FluGen":[11],"is":[12],"developing":[13],"M2SR":[14,24,46,75,125,228,288],"(M2":[15],"deficient":[16],"Single":[17],"Replication),":[18],"an":[19,60],"investigational,":[20],"live":[21],"virus":[22,146,173,324],"vaccine.":[23,211],"contains":[25],"the":[26,55,193,210],"internal":[27],"proteins":[28],"donor":[30],"A/Puerto":[31],"Rico/8/34":[32],"hemagglutinin":[34],"(HA)":[35],"neuraminidase":[37],"(NA)":[38],"selected":[39],"from":[40,112,179,330],"targeted":[41],"Type":[42],"A":[43,80,82],"influenza":[44,67,70,79,315],"strains.":[45],"undergoes":[47],"only":[48],"a":[49,96,118,206,267,300],"single":[50,97,119],"round":[51],"infection":[53],"in":[54,176,327],"respiratory":[56],"epithelium":[57],"but":[58],"evokes":[59],"immune":[61,286],"response":[62],"profile":[63],"similar":[64],"to":[65,209],"wild-type":[66],"viruses.":[68],"In":[69],"na\u00efve":[71],"pre-immune":[73],"ferrets,":[74],"protects":[76],"against":[77,310],"multiple":[78],"subtypes.":[81],"Phase":[83],"1,":[84],"first-in-human,":[85],"randomized,":[86],"placebo-control":[87],"study":[88,248],"(FluGen-H3N2-V001;":[89],"ClinicalTrials.gov":[90],"identifier":[91],"NCT02822105)":[92],"was":[93,174,188,220,290,325],"conducted":[94],"at":[95,126,266,295],"USA":[98],"site,":[99],"96":[101],"adults,":[102],"ages":[103],"18\u201349":[104],"years.":[105],"Study":[106,115,141],"vaccine":[107,272,289],"contained":[108],"HA":[109],"NA":[111],"A/Brisbane/10/2007":[113],"(H3N2).":[114],"volunteers":[116],"received":[117],"intranasal":[120],"(IN)":[121],"inoculation":[122],"either":[124],"dose":[127,297],"levels":[128],"106,":[130,231],"107":[131],"or":[132,135,205,233],"108":[133,234],"TCID50":[134],"saline":[136],"placebo":[137,240,274],"(N":[138],"=":[139],"24/cohort).":[140],"subjects":[142,229,275],"were":[143,214,243,264],"evaluated":[144],"for":[145,154,161,168,250,303,355,381,421,429],"replication":[147],"solicited":[149],"local":[150],"systemic":[152],"reactions":[153],"7":[155,195,282],"days,":[156],"all":[157,296],"adverse":[158,279],"events":[159,280],"(AE)":[160],"28":[162],"days":[163,196,283],"serious":[165],"AE":[166,187,219],"(SAE)":[167],"180":[169],"days.":[170],"No":[171,201,212,322],"infectious":[172,323],"detected":[175,265,326],"nasal":[177,190,328],"swabs":[178,329],"any":[180,331],"vaccinated":[181,332],"subject.":[182,333],"The":[183],"most":[184],"commonly":[185],"reported":[186,221],"mild":[189],"rhinorrhea/congestion":[191],"during":[192],"first":[194,281],"after":[197],"vaccination":[198],"(Figure":[199,276],"1).":[200],"subject":[202],"had":[203],"fever":[204],"severe":[207],"reaction":[208],"SAEs":[213],"reported.":[215],"At":[216],"least":[217],"one":[218],"among":[222,239,247,271],"29%,":[223],"58%,":[224],"83%":[226],"administered":[230],"107,":[232],"TCID50,":[235],"respectively,":[236],"46%":[238],"subjects.":[241],"There":[242],"no":[244],"notable":[245],"imbalances":[246],"groups":[249],"other":[251],"events.":[252],"T-":[253],"B-cell":[255],"responses,":[256],"including":[257],"influenza-specific":[258],"serum":[259],"mucosal":[261,308],"antibody":[262],"responses":[263,287],"significantly":[268],"higher":[269],"frequency":[270],"than":[273],"2).":[277],"Common":[278],"post-vaccination":[284],"Influenza-specific":[285],"safe":[291],"well":[293],"tolerated":[294],"levels,":[298],"generated":[299],"dose-response":[301],"effect":[302],"humoral":[304],"(HA":[305],"antibody)":[306],"antibodies":[309],"both":[311],"homologous":[312],"heterologous":[314],"variants,":[316],"elicited":[318],"robust":[319],"T-cell":[320],"responses.":[321],"J.":[334],"Eiden,":[335],"FluGen,":[336],"Inc.:":[337],"Consultant,":[338,347,360,369,462],"Consulting":[339,348,361,370,463],"fee":[340,362,371,420],"Stock":[342,364,373,389,397,405,413,440,446,457,471],"Options.":[343,365,390,398,406,414,441,447,458,472],"G.":[344,442],"Gordon,":[345],"FluGen:":[346,352,359,368,377,385,393,401,409,417,425,438,444,450,461,467],"fee.":[349,464],"C.":[350],"Fierro,":[351],"Investigator,":[353],"Fee":[354,380,428],"service.":[356,382,422,430],"R.":[357,407,459],"Belshe,":[358],"H.":[366],"Greenberg,":[367],"OpTions.":[374],"D.":[375,415],"Hoft,":[376],"Research":[378,418,426],"Contractor,":[379,419,427],"Y.":[383,436],"Hatta,":[384],"Employee,":[386,394,402,410,468],"Salary":[387,395,403,411,455,469],"M.":[391,399,423],"Imboden,":[392],"Moser,":[400],"Herber,":[408],"Boltz,":[416],"Tary-Lehmann,":[424],"CTL:":[431],"Founder":[432],"Owner,":[434],"Salary.":[435],"Kawaoka,":[437],"Founder,":[439,445,454],"Neumann,":[443],"P.":[448,465],"Radspinner,":[449],"Board":[451],"Member":[452],"Aitchison,":[460],"Bilsel,":[466]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2018-10-26T00:00:00"}